Opaleye Management Inc. - 01 Dec 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role: 10%+ Owner
Signature: /s/ James Silverman
Issuer symbol: N/A
Transactions as of: 01 Dec 2021
Net transactions value: +$53,287
Form type: 4
Filing time: 16 Dec 2021, 15:01:32 UTC
Previous filing: 19 Nov 2021
Next filing: 20 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCON	Common Stock, par value $0.001 per share	Purchase	$48,522	+20,000	+0.8%	$2.43^*	2,517,371	15 Dec 2021	By Opaleye, L.P.	F1
transaction	TCON	Common Stock, par value $0.001 per share	Purchase	$4,765	+1,964	+0.78%	$2.43^*	252,675	15 Dec 2021	By Managed Account	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TCON	Prefunded Warrants						1,889,513	01 Dec 2021	Common stock	1,889,513	$0.0100	By Opaleye,L.P.	F3, F4
holding	TCON	Prefunded Warrants						1,358,993	01 Dec 2021	Common stock	1,358,593	$0.0100	By Opaleye,L.P.	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The common stock was purchased by the reporting person in open market transactions on the transaction date with a volume weighted average purchase price of $2.4261 The range of purchase prices on the transaction date was $2.41-$2.45 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F2	Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3	Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F4	The warrants may not be exercised to the extent that such exercise would cause the reporting person and its affiliates to beneficially own more than 9.99% of the Issuer's then outstanding common stock.